Health Care & Life Sciences » Biotechnology | Human Stem Cells Institute PJS

Human Stem Cells Institute PJS | Income Statement

Fiscal year is January-December. All values RUB Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
419,770.00
359,371.00
310,821.00
390,356.00
494,441.00
644,688
Cost of Goods Sold (COGS) incl. D&A
209,132.00
203,212.00
194,408.00
271,439.00
369,084.00
358,868
Gross Income
210,638.00
156,159.00
116,413.00
118,917.00
125,357.00
285,820
SG&A Expense
166,446.00
200,228.00
216,468.00
261,372.00
176,490.00
214,446
EBIT
42,253.00
47,953.00
103,999.00
146,110.00
58,143.00
53,661
Unusual Expense
13,490.00
57,816.00
42,422.00
12,133.00
238.00
125,364
Non Operating Income/Expense
4,906.00
3,548.00
6,364.00
22,952.00
51,011.00
44,128
Interest Expense
18,503.00
15,567.00
8,646.00
27,078.00
30,757.00
30,242
Pretax Income
35,224.00
3,489.00
59,835.00
149,254.00
126,783.00
53,829
Income Tax
10,718.00
16,762.00
2,216.00
18,746.00
17,204.00
35,586
Equity in Affiliates
7,836.00
3,329.00
474.00
460.00
396.00
-
Consolidated Net Income
16,670.00
16,602.00
62,525.00
130,968.00
109,975.00
18,243
Net Income
14,722.00
13,193.00
51,537.00
111,309.00
102,601.00
34,208
Net Income After Extraordinaries
14,722.00
13,193.00
51,537.00
111,309.00
102,601.00
34,208
Net Income Available to Common
14,722.00
13,193.00
51,537.00
111,309.00
102,601.00
34,208
EPS (Basic)
0.20
0.18
0.69
1.48
1.37
0.46
Basic Shares Outstanding
71,993.80
71,993.80
75,000.00
75,000.00
75,000.00
75,000
EPS (Diluted)
0.20
0.18
0.69
1.48
1.37
0.46
Diluted Shares Outstanding
71,993.80
71,993.80
75,000.00
75,000.00
75,000.00
75,000
EBITDA
64,755.00
22,951.00
77,804.00
122,118.00
17,683.00
83,313
Other Operating Expense
1,939.00
3,884.00
3,944.00
3,655.00
7,010.00
17,713
Non-Operating Interest Income
2,890.00
5,645.00
4,024.00
3,913.00
10,185.00
3,269
Minority Interest Expense
1,948.00
3,409.00
10,988.00
19,659.00
7,374.00
15,965

About Human Stem Cells Institute PJS

View Profile
Address
18/1, Olimpiyskiy Avenue
Moscow MC 129110
Russian Federation
Employees -
Website http://www.hsci.ru
Updated 07/08/2019
Human Stem Cells Institute OJSC engages in the discovery, research, development, and marketing of proprietary products and services in the field of regenerative medicine, medical genetics, bio-insurance, gene therapy, and biopharmaceutics. Its research and development involves gemacell and cryocell; service for personal regeneration of bone and of gum; nucleostim; preventive treatment program for primary immunodeficiency diseases; human artificial chromosome; development of drugs using histone proteins; and development of drugs using a novel technology employing polysialic acid. The company was founded by Isaev Alexandrovich Artur on November 3, 2003 and is headquartered in Moscow, Russia.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.